子宮內避孕器市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Intrauterine Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於意外懷孕發生率上升和政府的支持性舉措，全球子宮內避孕器市場在 2023 年價值 43 億美元，到 2032 年將達到 101 億美元，2024 年至 2032 年複合年成長率為 10.3%。由於意外懷孕凸顯了有效避孕的必要性，越來越多人開始使用子宮內的避孕器來進行可靠、長期的預防。此外，促進計劃生育和生殖健康的政府計劃提高了子宮內避孕器的可及性和認知。這些綜合因素可能會促進子宮內避孕器的採用，促進市場擴張並滿足對有效避孕解決方案不斷成長的需求。

子宮內避孕器產業根據產品、年齡層、最終用途和地區進行分類。

由於其有效性和相對於傳統方法的額外優勢，荷爾蒙子宮內避孕器細分市場在 2023 年將獲得 23 億美元的收入。荷爾蒙子宮內避孕器可提供長期避孕作用，同時還具有減少月經出血和緩解經痛等好處，使其對使用者極具吸引力。荷爾蒙子宮內避孕器技術的進步以及人們對這些益處的認知不斷提高，進一步推動了其普及。隨著對更有效和方便用戶使用的避孕選擇的需求不斷成長，激素子宮內避孕器將引領市場。

由於對專業醫療服務和綜合生殖保健的高需求的推動，到2023年，醫院部門將佔據46.8%的佔有率。醫院提供一系列專業服務，包括子宮內避孕器的放置和管理，吸引尋求可靠和專業避孕解決方案的患者。此外，醫院配備了先進的設施和訓練有素的醫療保健專業人員，提高了子宮內避孕器的採用率。隨著醫療機構繼續優先考慮計劃生育，醫院部門將主導市場。

由於先進的醫療基礎設施、對生殖健康的高度認知以及現代避孕方法的廣泛採用，北美子宮內避孕器市場在 2023 年累計達到 15 億美元。該地區受益於醫療保健和計劃生育服務的大量投資，增強了子宮內避孕器的可近性和教育。此外，有利的政府政策和對女性健康的強烈關注進一步推動市場成長。北美強大的醫療保健系統和積極主動的方法使其成為子宮內避孕器行業的關鍵貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 女性對各種子宮內避孕器應用的認知不斷提高
  - 意外懷孕率很高
  - 政府預防意外墮胎和懷孕的舉措
  - 越來越傾向於計劃性延遲妊娠
- 產業陷阱與挑戰
  - 設備成本高
  - 多種健康問題的風險
  - 保險範圍和獲取途徑的可變性
成長潛力分析
技術景觀
未來市場趨勢
監管環境
- 美國
- 歐洲
- 亞太地區
報銷場景
- 北美洲
- 歐洲
- 亞太地區
定價分析
差距分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
含銅子宮內避孕器
荷爾蒙子宮內避孕器

第 6 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
15-19日
20-24日
25-29日
30-34
35-39
40-44
45+

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
婦科診所
社區健康服務中心

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Allergan (AbbVie Inc.)
Bayer AG
Contrel Europe
CooperSurgical Inc.
Durbin
EUROGINE, SL
Gima SpA
HLL Lifecare Limited
Meril Life Sciences Pvt. Ltd.
Mona Lisa NV
Mylan NV (Viatris)
OCON Medical Ltd.
Pregna International Ltd.
Prosan International BV
SMB Corporation of India

簡介目錄

Product Code: 5451

The Global Intrauterine Devices Market, worth USD 4.3 billion in 2023, will achieve USD 10.1 billion by 2032 at a 10.3% CAGR from 2024 to 2032, owing to the rising incidence of unplanned pregnancies and supportive government initiatives. As unplanned pregnancies highlight the need for effective contraception, more individuals are turning to IUDs for reliable, long-term prevention. Additionally, government programs promoting family planning and reproductive health enhance accessibility and awareness of IUDs. These combined factors are likely to boost the adoption of IUDs, contributing to the market's expansion and addressing the growing demand for effective contraceptive solutions.

The intrauterine devices industry is segregated on the basis of product, age group, end use , and region.

The hormonal IUD segment secured USD 2.3 billion in 2023 due to its effectiveness and additional benefits over traditional methods. Hormonal IUDs provide long-term contraception while also offering benefits like reduced menstrual bleeding and alleviation of menstrual cramps, making them highly appealing to users. Advances in hormonal IUD technology and increasing awareness of these benefits further drive their popularity. As demand for more effective and user-friendly contraceptive options grows, hormonal IUDs will lead the market.

The hospital segment held 46.8% share in 2023, driven by the high demand for professional medical services and comprehensive reproductive health care. Hospitals offer a range of specialized services, including the insertion and management of IUDs, attracting patients seeking reliable and expert contraceptive solutions. Additionally, hospitals are equipped with advanced facilities and trained healthcare professionals, enhancing the adoption of IUDs. As healthcare facilities continue to prioritize family planning, the hospital segment will dominate the market.

North America intrauterine devices market accumulated USD 1.5 billion in 2023, fueled by its advanced healthcare infrastructure, high awareness of reproductive health, and widespread adoption of modern contraceptive methods. The region benefits from significant investments in healthcare and family planning services, enhancing accessibility and education about IUDs. Additionally, favorable government policies and a strong focus on women's health further drive market growth. North America's robust healthcare system and proactive approach make it a key contributor to the intrauterine devices industry.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising awareness among women regarding various IUD applications
  - 3.2.1.2 High number of unintended pregnancies
  - 3.2.1.3 Government initiatives for the prevention of unwanted abortions and pregnancies
  - 3.2.1.4 Growing inclination towards planned delayed pregnancy
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of device
  - 3.2.2.2 Risk of several health issues
  - 3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
- 3.6.3 Asia Pacific
3.7 Reimbursement scenario
- 3.7.1 North America
- 3.7.2 Europe
- 3.7.3 Asia Pacific
3.8 Pricing analysis
3.9 Gap analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Copper IUD
5.3 Hormonal IUD

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 15-19
6.3 20-24
6.4 25-29
6.5 30-34
6.6 35-39
6.7 40-44
6.8 45+

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Gynecology clinics
7.4 Community health care centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa